Free Trial
NASDAQ:PULM

Pulmatrix (PULM) Stock Price, News & Analysis

Pulmatrix logo
$4.95 -0.01 (-0.20%)
As of 01:22 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Pulmatrix Stock (NASDAQ:PULM)

Key Stats

Today's Range
$4.91
$4.93
50-Day Range
$4.47
$7.43
52-Week Range
$1.78
$10.40
Volume
10,844 shs
Average Volume
27,044 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pulmatrix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

PULM MarketRank™: 

Pulmatrix scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pulmatrix.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pulmatrix is -2.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pulmatrix is -2.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pulmatrix has a P/B Ratio of 2.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Pulmatrix's valuation and earnings.
  • Percentage of Shares Shorted

    0.47% of the float of Pulmatrix has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulmatrix has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pulmatrix has recently decreased by 32.68%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Pulmatrix does not currently pay a dividend.

  • Dividend Growth

    Pulmatrix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.47% of the float of Pulmatrix has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulmatrix has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pulmatrix has recently decreased by 32.68%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Pulmatrix has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Pulmatrix this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for PULM on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Pulmatrix to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pulmatrix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.62% of the stock of Pulmatrix is held by insiders.

  • Percentage Held by Institutions

    Only 11.84% of the stock of Pulmatrix is held by institutions.

  • Read more about Pulmatrix's insider trading history.
Receive PULM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulmatrix and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PULM Stock News Headlines

Pulmatrix Reports Q2 2025 Results and Merger Plans
Pulmatrix (PULM) Q2 Revenue Falls 100%
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
Pulmatrix Inc.
See More Headlines

PULM Stock Analysis - Frequently Asked Questions

Pulmatrix's stock was trading at $6.98 at the start of the year. Since then, PULM shares have decreased by 29.1% and is now trading at $4.95.

Pulmatrix, Inc. (NASDAQ:PULM) issued its quarterly earnings results on Wednesday, August, 6th. The biotechnology company reported ($0.42) EPS for the quarter. Pulmatrix had a negative trailing twelve-month return on equity of 97.25% and a negative net margin of 122.46%.

Pulmatrix shares reverse split on the morning of Tuesday, March 1st 2022.The 1-20 reverse split was announced on Tuesday, March 1st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 1st 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Top institutional shareholders of Pulmatrix include SBI Securities Co. Ltd..
View institutional ownership trends
.

Shares of PULM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulmatrix investors own include NVIDIA (NVDA), CymaBay Therapeutics (CBAY), GE Aerospace (GE), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO) and Adobe (ADBE).

Company Calendar

Last Earnings
8/06/2025
Today
8/29/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PULM
CIK
1574235
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.17)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.94 million
Net Margins
-122.46%
Pretax Margin
-1,439.57%
Return on Equity
-97.25%
Return on Assets
-88.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.21
Quick Ratio
11.21

Sales & Book Value

Annual Sales
$7.81 million
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.45 per share
Price / Book
2.02

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.45

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:PULM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners